Skip to main content

Table 2 Baseline characteristics of the participants with and without chronic kidney disease

From: Chronic kidney disease and undiagnosed atrial fibrillation in individuals with diabetes

Characteristic

No (%)

Total participants with diabetes

(N = 608)

P

Non-chronic kidney disease group

Chronic kidney disease group

(N = 512)

(N = 96)

Age, mean (SD), y

70.4 (6.8)

73.2 (6.0)

< 0.001

CHA2DS2-VASC score, mean (SD)a

3.09 (1.43)

3.69 (1.34)

< 0.001

Men

356 (69.5)

58 (60.4)

0.052

Atrial fibrillation

12 (2.3)

7 (7.3)

0.02

Atrial fibrillation by claim

8 (1.6)

6 (6.3)

0.014

Beta blocker

101 (19.7)

14 (14.6)

0.149

Digoxin

3 (0.6)

0 (0)

0.597

Comorbidities

 Hypertension

475 (92.8)

94 (97.9)

0.038

 Obesityb

125 (24.4)

20 (20.8)

0.269

 Heart failure

23 (4.5)

12 (12.5)

0.004

 Chronic obstructive pulmonary disease

29 (5.7)

11 (11.5)

0.036

 Stroke

65 (12.7)

8 (8.3)

0.149

 Prior myocardial infarction

27 (5.3)

9 (9.4)

0.097

 Sleep apnea

143 (27.9)

28 (29.2)

0.446

  1. Results are expressed as frequencies (percentage) and mean values (standard deviation) as appropriate
  2. CHA2DS2-VASC, congestive heart failure, hypertension, age ≥ 75 years (doubled), diabetes, stroke/transient ischemic attack/thromboembolism (doubled), vascular disease (prior myocardial infarction, peripheral artery disease, or aortic plaque), age 65–75 years, sex category (female)
  3. aCHA2DS2-VASC score is a clinical prediction score for estimating the risk of stroke in individuals with nonrheumatic atrial fibrillation. An individual’s score can range from 0 to 9, with a high score associated with higher risk. Components include congestive heart failure (1 point); hypertension (1 point); age 75 years (2 points); diabetes (1 point); prior stroke or transient ischemic attack (2 points); vascular disease (1 point); age 65–74 years (1 point); and sex category (female;1 point)
  4. bObesity is defined through the Health Profile Database using a combination of a data types including a documented body mass index of 30 or greater and/or an obesity-related diagnosis or procedure (e.g., bariatric surgery)